Get the app
HealthcareMachine Learning4 min reading time

AI drug development startup Pathos AI closes $237M investment

SiliconANGLE
Read the full article
Pathos AI raised $237M at a $3B valuation to advance its AI-driven cancer drug development platform, Foundry, which analyzes vast oncological data to identify promising drug candidates and plan biomarker-driven clinical trials.
#astrazeneca#bristol-myers-squibb#clinical-trials#drug-discovery#foundry#oncology#pathos-ai

More in Healthcare

Healthcare5 min read

Microsoft says its AI tool is better than doctors at diagnosing conditions

Covered by 5 sources
Healthcare3 min read

What is Warhound, Palmer Luckey's war dog startup that just emerged from stealth?

Covered by 2 sources
Healthcare7 min read

Bringing foundational models to the front lines of TB screening

Google Research Blog